Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 21623600)

1.

Anti-proteinuric effect of sulodexide in immunoglobulin a nephropathy.

Bang K, Chin HJ, Chae DW, Joo KW, Kim YS, Kim S, Ju KD, Kim H, Ahn C, Oh KH.

Yonsei Med J. 2011 Jul;52(4):588-94. doi: 10.3349/ymj.2011.52.4.588.

2.

Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.

Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC; HKVIN Study Group.

Am J Kidney Dis. 2006 May;47(5):751-60.

PMID:
16632013
4.

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.

Heerspink HL, Greene T, Lewis JB, Raz I, Rohde RD, Hunsicker LG, Schwartz SL, Aronoff S, Katz MA, Eisner GM, Mersey JH, Wiegmann TB; Collaborative Study Group.

Nephrol Dial Transplant. 2008 Jun;23(6):1946-54. Epub 2007 Dec 18.

5.

Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.

Lambers Heerspink HJ, Fowler MJ, Volgi J, Reutens AT, Klein I, Herskovits TA, Packham DK, Fraser IR, Schwartz SL, Abaterusso C, Lewis J; Collaborative Study Group.

Diabet Med. 2007 Nov;24(11):1290-5.

PMID:
17956455
6.
7.

ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.

Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccalà A, Zucchelli P.

Nephrol Dial Transplant. 1994;9(3):265-9.

PMID:
8052432
8.

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

Manno C, Torres DD, Rossini M, Pesce F, Schena FP.

Nephrol Dial Transplant. 2009 Dec;24(12):3694-701. doi: 10.1093/ndt/gfp356. Epub 2009 Jul 23. Erratum in: Nephrol Dial Transplant. 2010 Apr;25(4):1363-4.

9.

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group.

Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Erratum in: Am J Kidney Dis. 2012 Feb;59(2):318.

PMID:
21872376
10.

Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.

Packham DK, Wolfe R, Reutens AT, Berl T, Heerspink HL, Rohde R, Ivory S, Lewis J, Raz I, Wiegmann TB, Chan JC, de Zeeuw D, Lewis EJ, Atkins RC; Collaborative Study Group.

J Am Soc Nephrol. 2012 Jan;23(1):123-30. doi: 10.1681/ASN.2011040378. Epub 2011 Oct 27.

11.

Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.

Manno C, Gesualdo L, D'Altri C, Rossini M, Grandaliano G, Schena FP.

J Nephrol. 2001 Jul-Aug;14(4):248-52.

PMID:
11506246
12.

Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial.

Liu LJ, Lv JC, Shi SF, Chen YQ, Zhang H, Wang HY.

Am J Kidney Dis. 2012 Jan;59(1):67-74. doi: 10.1053/j.ajkd.2011.09.014. Epub 2011 Oct 22.

PMID:
22019331
13.

Cyclosporin treatment of IgA nephropathy: a short term controlled trial.

Lai KN, Lai FM, Li PK, Vallance-Owen J.

Br Med J (Clin Res Ed). 1987 Nov 7;295(6607):1165-8.

14.

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.

Gambaro G, Kinalska I, Oksa A, Pont'uch P, Hertlová M, Olsovsky J, Manitius J, Fedele D, Czekalski S, Perusicová J, Skrha J, Taton J, Grzeszczak W, Crepaldi G.

J Am Soc Nephrol. 2002 Jun;13(6):1615-25.

15.

Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.

Sulikowska B, Olejniczak H, Muszyńska M, Odrowaz-Sypniewska G, Gaddi A, Savini C, Cicero AF, Laghi L, Manitius J.

Am J Nephrol. 2006;26(6):621-8. Epub 2006 Dec 21.

PMID:
17191008
16.

The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.

Donadio JV Jr, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC.

J Am Soc Nephrol. 1999 Aug;10(8):1772-7.

17.

Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy.

Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G, Corsonello A, Senatore M, Frisina N.

Clin Pharmacol Ther. 2000 Apr;67(4):427-31.

PMID:
10801253
19.
20.

Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.

Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.

Nephrol Dial Transplant. 2003 Jun;18(6):1115-21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk